Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
1.
Surg Obes Relat Dis ; 16(8): 1069-1077, 2020 Aug.
Article in English | MEDLINE | ID: mdl-32660800

ABSTRACT

BACKGROUND: Bariatric surgery is 1 of the major treatments of obesity. OBJECTIVES: This study describes the development of the bariatric surgery in France and look at some factors of this evolution. SETTING: It concerns the activity of all the French hospitals over a 22-year period. METHODS: Hospitalization databases from 1997 to 2018 have been used to study the evolution of the number of bariatric operations, their types, the characteristics of both patients and hospitals performing this surgery. RESULTS: The number of operations grew from 2800 in 1997 to 52,500 in 2018, with 2 interruptions in this growth, in 2002 and from 2017 to date. The rate of operations is 4 times higher for women than for men, with a peak in the 35-44 age group. The adjustable gastric banding was the most popular operation until 2010, then replaced by sleeve gastrectomy since 2010. Private for-profit hospitals carried out the majority of these operations, even if the public hospitals activity progressed regularly during the past 2 decades. CONCLUSIONS: Compared to other countries, the rate of bariatric operations in France is rather high whereas the obesity rate is medium to low. Easy accessibility to bariatric surgery should play a role in the high rate, but specific studies are necessary to evaluate if the operations are delivered adequately to the obese population.


Subject(s)
Bariatric Surgery , Laparoscopy , Obesity, Morbid , Female , France/epidemiology , Gastrectomy , Humans , Male , Obesity , Obesity, Morbid/epidemiology , Obesity, Morbid/surgery
2.
Stroke ; 50(2): 305-312, 2019 02.
Article in English | MEDLINE | ID: mdl-30621528

ABSTRACT

Background and Purpose- The aims of this study were to (1) describe early and late case fatality rates after stroke in France, (2) evaluate whether their determinants differed, and (3) analyze time trends between 2010 and 2015. Methods- Data were extracted from the Système National des données de santé database. Patients hospitalized for stroke each year from 2010 to 2015, aged ≥18 years, and affiliated to the general insurance scheme were selected. Cox regressions were used to separately analyze determinants of 30-day and 31- to 365-day case fatality rates for each stroke type (ischemic, intracerebral hemorrhage, and subarachnoid hemorrhage). Results- In 2015, of the 73 124 persons hospitalized for stroke, 26.8% died in the following year, with the majority of deaths occurring within the first 30 days (56.9%). Nonadmission to a stroke unit, older age, and having comorbidities were all associated with a poorer 30-day and 31- to 365-day prognosis. Female sex was associated with a lower 31- to 365-day case fatality rate for all patients with stroke. Living in an area with a high deprivation index was associated with both higher 30-day and 31- to 365-day case fatality rates for all stroke types. Between 2010 and 2015, significant decreases in both 30-day and 31- to 365-day case fatality rates for ischemic patients were observed. Conclusions- Case fatality rates after stroke remained high in 2015 in France, despite major improvements in stroke care and organization. Improvement in stroke awareness and preparedness, particularly in the most deprived areas, together with better follow-up after the acute phase are urgently needed.


Subject(s)
Brain Ischemia/mortality , Cerebral Hemorrhage/mortality , Adolescent , Adult , Age Distribution , Aged , Aged, 80 and over , Antihypertensive Agents/therapeutic use , Comorbidity , Databases, Factual , Female , France/epidemiology , Hospital Mortality , Hospitalization/statistics & numerical data , Humans , Hypertension/drug therapy , Hypertension/epidemiology , Male , Middle Aged , Mortality/trends , Prognosis , Sex Distribution , Subarachnoid Hemorrhage/mortality , Young Adult
3.
BMJ Open ; 8(9): e023599, 2018 09 28.
Article in English | MEDLINE | ID: mdl-30269075

ABSTRACT

OBJECTIVES: We aimed to study trends in stroke unit (SU) admission during a period of their deployment in France and to assess whether this led to better and more equitable access to this specialised care. DESIGN: Analysis of records from the national hospital database. SETTING: All acute care hospitals in metropolitan France for the period 2009-2014. PARTICIPANTS: Over 600 000 patients admitted in acute care with a main diagnosis of stroke. MAIN OUTCOME MEASURES: Admission to a SU. RESULTS: Between 2009 and 2014, the number of stroke admissions rose from 93 728 to 109 456, and the proportion of SU admission from 23% to 44%. Overall, characteristics associated with higher probability of SU admission were: male gender, younger age, ischaemic stroke type, medium level of comorbidity and larger size of town of residence. Although likelihood of SU admission increased in all patients' categories during the study period, we identified steeper positive temporal trends among older patients, those with more comorbidities and those residing in medium or small towns (all p values <0.001), suggesting a 'catching up' phenomena. Temporal trends of men and women did not differ however. CONCLUSIONS: Admission to SU nearly doubled in France between 2009 and 2014. Faster trends observed for patients with lower admission to SU suggest that equity in access has improved over the period.


Subject(s)
Patient Admission/trends , Stroke/epidemiology , Age Factors , Aged , Aged, 80 and over , Comorbidity , Databases, Factual , Female , France/epidemiology , Hospital Units , Humans , Male , Middle Aged , Patient Admission/statistics & numerical data , Residence Characteristics , Sex Factors
4.
J Stroke Cerebrovasc Dis ; 27(12): 3443-3450, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30190227

ABSTRACT

GOAL: We studied time trends of admission in neurological rehabilitation units (NRU) among patients hospitalised for stroke from 2010 to 2014 and compared prognostic factors of functional gain, home return and inpatient survival. METHODS: Patients hospitalized for Stroke from 2010 to 2014 were selected from the French national hospital databases. Admission in rehabilitation was searched till 3 months. Predictive factors of functional gain, home return, in-patient survival, and the corresponding trends were studied using logistic regression. RESULTS: In 2014, global rehabilitation rate was 36.3% with 15.8 discharged in a NRU. The rate of patients managed in NRU rose between 2010 and 2014. An increase in the proportion of home return (+4%) and inpatient survival rate (+7%) were observed between 2010 and 2014. Almost 40% of patients with severe functional deficits benefited of a partial or complete recovery after their rehabilitation stay. NRU admission was associated with higher probability of functional gain (OR [odds ratio] =1.76 [confidence interval {CI} 95% 1.67-1.85]), home return (OR = 1.38 [CI 95% 1.29-1.47]) and inpatient survival (OR = 3.15 [CI 95% 2.83-3.52]). CONCLUSIONS: A greater proportion of patients were admitted in NRU along with an increase of home return and in-patient survival, but too many patients remained excluded.


Subject(s)
Patient Admission , Rehabilitation Centers , Stroke Rehabilitation , Aged , Aged, 80 and over , Brain Ischemia/diagnosis , Brain Ischemia/epidemiology , Brain Ischemia/rehabilitation , Cerebral Hemorrhage/diagnosis , Cerebral Hemorrhage/epidemiology , Cerebral Hemorrhage/rehabilitation , Female , Follow-Up Studies , France/epidemiology , Hospital Mortality , Humans , Length of Stay , Male , Middle Aged , Prognosis , Recovery of Function , Retrospective Studies , Stroke/diagnosis , Stroke/epidemiology
5.
Arch Cardiovasc Dis ; 111(11): 625-633, 2018 Nov.
Article in English | MEDLINE | ID: mdl-29133181

ABSTRACT

BACKGROUND: Follow-up care and rehabilitation services [soins de suite et réadaptation (SSR)], especially cardiac rehabilitation (CR), constitute a key stage for patients who have had an acute myocardial infarction (AMI). AIMS: To study admission to SSR, especially for CR, among patients hospitalized for AMI in France in 2014, and its temporal trend between 2010 and 2014. METHODS: We used the French National Hospital Database to select patients hospitalized with a main diagnosis of AMI (identified by ICD-10 codes I21 to I23) in the first semester of each year from 2010 to 2014. We then searched for rehabilitation admission in the 6 months after the index hospitalization. We calculated age-standardized rates of admission for CR and for other rehabilitation purposes. The average annual percentage change in admission rates was analysed by Poisson regression. RESULTS: In 2014, among the 29,424 patients hospitalized for an AMI in the first 6 months of the year, 10,873 (36.9%) were subsequently admitted to SSR units. More specifically, the age-standardized rate of patients hospitalized in CR units reached 28.4% (n=8380), and was greater among men (29.6%, n=6707) than among women (24.9%, n=1673). Between 2010 and 2014, rates of admission for CR increased by 5.0% per year in men and 6.6% per year in women. We found a great increase in ambulatory CR management, which accounted for half of the admissions for CR in 2014. CONCLUSIONS: Favourable trends in rates of admission for CR were reported in both sexes and at all ages, except the oldest. The increase in ambulatory management contributed to these changes. Despite these trends, rates of admission for CR after AMI remain low.


Subject(s)
Cardiac Rehabilitation/trends , Myocardial Infarction/therapy , Patient Admission/trends , Practice Patterns, Physicians'/trends , Adult , Age Factors , Aged , Aged, 80 and over , Databases, Factual , Female , France/epidemiology , Humans , Male , Middle Aged , Myocardial Infarction/diagnosis , Myocardial Infarction/epidemiology , Myocardial Infarction/physiopathology , Sex Factors , Time Factors , Treatment Outcome
6.
Stroke ; 48(11): 2939-2945, 2017 11.
Article in English | MEDLINE | ID: mdl-28970279

ABSTRACT

BACKGROUND AND PURPOSE: Stroke is the leading cause of death in women and the third leading cause in men in France. In young adults (ie, <65 years old), an increase in the incidence of ischemic stroke was observed at a local scale between 1985 and 2011. After the implementation of the 2010 to 2014 National Stroke Action Plan, this study investigates national trends in patients hospitalized by stroke subtypes, in-hospital mortality, and stroke mortality between 2008 and 2014. METHODS: Hospitalization data were extracted from the French national hospital discharge databases and mortality data from the French national medical causes of death database. Time trends were tested using a Poisson regression model. RESULTS: From 2008 to 2014, the age-standardized rates of patients hospitalized for ischemic stroke increased by 14.3% in patients <65 years old and decreased by 1.5% in those aged ≥65 years. The rate of patients hospitalized for hemorrhagic stroke was stable (+2.0%), irrespective of age and sex. The proportion of patients hospitalized in stroke units substantially increased. In-hospital mortality decreased by 17.1% in patients with ischemic stroke. From 2008 to 2013, stroke mortality decreased, except for women between 45 and 64 years old and for people aged ≥85 years. CONCLUSIONS: An increase in cardiovascular risk factors and improved stroke management may explain the increase in the rates of patients hospitalized for ischemic stroke. The decrease observed for in-hospital stroke mortality may be because of recent improvements in acute-phase management.


Subject(s)
Databases, Factual , Hospital Mortality , Hospitalization , Intracranial Hemorrhages/mortality , Stroke/mortality , Aged , Aged, 80 and over , Female , France/epidemiology , Humans , Male , Middle Aged , Risk Factors , Sex Factors
7.
Thromb Res ; 135(2): 334-8, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25511577

ABSTRACT

BACKGROUND: Pulmonary Embolism (PE) is a potentially fatal complication of venous thrombosis. Recent and comprehensive estimates of PE incidence and mortality are scarce. Moreover, while contemporary mortality trends of PE would enable the evaluation of prevention and quality of care, such data are lacking. The aim of this study was to provide nationwide estimations of PE mortality and time trends in France between 2000 and 2010. METHODS: Mortality data were obtained from the French Epidemiology Center on medical causes of death. Mortality rates were calculated with PE as an underlying or one of multiple causes of death. The annual percentage changes were assessed using a Poisson regression model. Age-standardized PE mortality rates were also assessed. RESULTS: In 2010, the overall age-adjusted PE mortality rate was 21.0 per 100000. This rate was 30% higher in men than in women and decreased by 3% per year between 2000 and 2010. Over this period, PE mortality declined in men and women over 55 years but only slightly decreased in patients younger than 55. Cancer, obesity, osteopathies and complications of surgery were often coded as the underlying causes of death when PE was an associated cause of death recorded on certificate. DISCUSSION: This study is the first to provide a contemporary and exhaustive nationwide estimation of PE mortality and time trends in France. The observed decrease in PE mortality between 2000 and 2010 is encouraging, but further efforts in prevention are needed to ensure that this reduction is widespread in all age groups.


Subject(s)
Pulmonary Embolism/epidemiology , Pulmonary Embolism/mortality , Cause of Death , Female , France , History, 21st Century , Humans , Male , Time Factors
8.
PLoS One ; 9(12): e115375, 2014.
Article in English | MEDLINE | ID: mdl-25521057

ABSTRACT

In France, the prevalence of stroke and the level of disability of stroke survivors are little known. The aim of this study was to evaluate functional limitations in adults at home and in institutions, with and without self-reported stroke. A survey named "the Disability Health survey" was carried out in people's homes (DHH) and in institutions (DHI). Medical history and functional level (activities-of-daily-living, ADL and instrumented-activities-of-daily-living IADL) were collected through interviews. The modified Rankin score (mRS) and the level of dependence and disability were compared between participants with and without stroke. 33896 subjects responded. The overall prevalence of stroke was 1.6% (CI95% [1.4%-1.7%]). The mRS was over 2 for 34.4% of participants with stroke (28.7% of participants at home and 87.8% of participants in institutions) versus respectively 3.9%, 3.1% and 71.6% without stroke. Difficulty washing was the most frequently reported ADL for those with stroke (30.6% versus 3% for those without stroke). Difficulty with ADL and IADL increased with age but the relative risk was higher below the age of 60 (17 to 25) than over 85 years (1.5 to 2.2), depending on the ADL. In the overall population, 22.6% of those confined to bed or chair reported a history of stroke. These results thus demonstrate a high national prevalence of stroke. Older people are highly dependent, irrespective of stroke history and the relative risk of dependence in young subjects with a history of stroke is high compared with those without.


Subject(s)
Activities of Daily Living , Self Report , Stroke/epidemiology , Adolescent , Adult , Age Factors , Aged , Aged, 80 and over , Disability Evaluation , Female , France , Humans , Male , Middle Aged , Prevalence , Stroke/psychology , Stroke Rehabilitation
9.
Int J Cardiol ; 173(3): 430-5, 2014 May 15.
Article in English | MEDLINE | ID: mdl-24679692

ABSTRACT

BACKGROUND: The frequencies of treated cardiovascular disease (CVD) and their associated risk factors (CVRF) may vary according to socioeconomic and territorial characteristics. METHODS: These frequencies have been described for 48million policyholders of the French general health insurance scheme, according to a metropolitan geographical deprivation index in five quintiles (from the least to the most deprived: Q1 to Q5), the existence of universal complementary health cover (CMUC) in individuals under the age of 60, and residence in a French overseas territory (FOT). The information system (SNIIRAM) was used to identify CVDs and anti-diabetic, anti-hypertensive or lipid-lowering treatments by three reimbursements in 2010. RESULTS: After age- and sex-specific adjustment, the inhabitants of the most deprived areas more often suffered from distal arterial disease (Q5/Q1=1.5), coronary artery disease (1.2) and cerebral vascular accident (1.1), as did the CMUC beneficiaries compared to non-beneficiaries (ratios of 1.7, 1.3 and 1.5), and the FOT residents in comparison to the most deprived metropolitan quintile (Q1), with the exception of coronary artery disease (1.2, 0.6 and 1.2). Inhabitants of the most deprived areas more often received anti-diabetic and anti-hypertensive treatment (Q5/Q1=1.4 and 1.2), as did the people on the CMUC (2.0 and 1.2) and the FOT inhabitants (FOT/Q1=2.4 and 1.3). These ratios were of 1.1, 1.0 and 0.8 for lipid-lowering drugs. CONCLUSION: These results pinpoint populations for which specific preventative initiatives could be supported. While health care service utilisation is facilitated (CMUC), it is probably not yet effective enough in view of the persistent increased cardiovascular risk.


Subject(s)
Cardiovascular Diseases/economics , Cardiovascular Diseases/ethnology , Developing Countries/economics , National Health Programs/economics , Residence Characteristics , Adult , Cardiovascular Diseases/therapy , Female , France/ethnology , Humans , Male , Middle Aged , Poverty/economics , Poverty/ethnology , Risk Factors , Socioeconomic Factors , Treatment Outcome , Young Adult
10.
Arch Cardiovasc Dis ; 107(3): 158-68, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24662470

ABSTRACT

BACKGROUND: National population-based management and outcome data for patients of all ages hospitalized for heart failure have rarely been reported. AIM: National population-based management and outcome of patients of all ages hospitalized for heart failure have rarely been reported. The present study reports these results, based on 77% of the French population, for patients hospitalized for the first time for heart failure in 2009. METHODS: The study population comprised French national health insurance general scheme beneficiaries hospitalized in 2009 with a principal diagnosis of heart failure, after exclusion of those hospitalized for heart failure between 2006 and 2008 or with a chronic disease status for heart failure. Data were collected from the national health insurance information system (SNIIRAM). RESULTS: A total of 69,958 patients (mean age, 78 years; 48% men) were studied. The hospital mortality rate was 6.4%, with 1-month, 1-year and 2-year survival rates of 89%, 71% and 60%, respectively. Heart failure and all-cause readmission-free rates were 55% and 43% at 1 year and 27% and 17% at 2 years, respectively. Compared with a reference sample of 600,000 subjects, the age- and sex-standardized relative risk of death was 29 (95% confidence interval [CI] 28-29) at 2 years, 82 (95% CI 72-94) in subjects aged<50 years and 3 (95% CI 3-3) in subjects aged ≥ 90 years. For subjects aged < 70 years who survived 1 month after discharge, factors associated with a reduction in the 2-year mortality rate were: female sex; age < 55 years; absence of co-morbidities; and use of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, beta-blockers, lipid-lowering agents or oral anticoagulants during the month following discharge. Poor prognostic factors were treatment with a loop diuretic before or after hospitalization and readmission for heart failure within 1 month after discharge. CONCLUSIONS: This large population-based study confirms the severe prognosis of heart failure and the need to promote the use of effective medications and management designed to improve survival.


Subject(s)
Heart Failure/mortality , Hospitalization , Aged , Aged, 80 and over , Cardiology , Cardiovascular Agents/therapeutic use , Cause of Death , Comorbidity , Disease Management , Female , Follow-Up Studies , France/epidemiology , Heart Failure/drug therapy , Humans , Hypolipidemic Agents/therapeutic use , Male , Middle Aged , National Health Programs , Patient Readmission/statistics & numerical data , Prognosis , Referral and Consultation , Risk Factors , Sodium Potassium Chloride Symporter Inhibitors/therapeutic use , Survival Rate , Treatment Outcome
11.
Neurorehabil Neural Repair ; 28(1): 36-44, 2014 Jan.
Article in English | MEDLINE | ID: mdl-23897907

ABSTRACT

BACKGROUND: In France in 2009, patients admitted to Multidisciplinary Inpatient Rehabilitation for stroke were sent to a neurological rehabilitation center (NRC) or a general or geriatric rehabilitation (GRC) service. OBJECTIVE: To describe the functional outcome of stroke patients admitted for rehabilitation in France in 2009, both globally and as a function of the rehabilitation setting (GRC or NRC). METHODS: Data from the French Hospital Discharge Diagnosis databases for 2009 were included. Two logistic regression models were used to analyze factors related to improvement in dependence score and discharge home. Odds ratios (ORs) were also calculated. RESULTS: Among the 83 505 survivors of acute stroke in 2009, 28 201 were admitted for rehabilitation (33.8%). Of these, 19 553 went to GRC (69%) and 8648 to NRC (31%). On average, patients admitted to GRC were older (78.6 years vs 66.4 years), P < .001). At the start of rehabilitation, 50% of NRC patients and 56% of GRC patients were heavily dependent, but level of dependence was similar within each age-group. Rehabilitation in NRC lead to a greater probability of functional improvement (OR = 1.75, P < .001) and home discharge (OR = 1.61, P < .001) after adjustment for gender, age, Charlson's comorbidity index, initial level of dependence, type of stroke, and total length of stay. CONCLUSION: This study confirms, on a national level, the functional benefit of specialized rehabilitation in NRC. These results should be useful in the improvement of care pathways, organization of rehabilitation, and discharge planning.


Subject(s)
Inpatients , Recovery of Function/physiology , Rehabilitation Centers , Stroke Rehabilitation , Age Factors , Aged , Aged, 80 and over , Databases, Factual , Female , France , Humans , Length of Stay , Male , Middle Aged , Patient Discharge , Stroke/physiopathology , Treatment Outcome
12.
Arch Cardiovasc Dis ; 106(11): 570-85, 2013 Nov.
Article in English | MEDLINE | ID: mdl-24140417

ABSTRACT

BACKGROUND: The incidence of heart failure (HF) is stable in industrialized countries, but its prevalence continues to increase, especially due to the ageing of the population, and mortality remains high. OBJECTIVE: To estimate the incidence in France and describe the management and short-term outcome of patients hospitalized for HF for the first time. METHOD: The study population comprised French national health insurance general scheme beneficiaries (77% of the French population) hospitalized in 2009 with a principal diagnosis of HF after exclusion of those hospitalized for HF between 2006 and 2008 or with a chronic disease status for HF. Data were collected from the national health insurance information system (SNIIRAM). RESULTS: A total of 69,958 patients (mean age 78 years; 48% men) were included. The incidence of first hospitalization for HF was 0.14% (≥ 55 years, 0.5%; ≥ 90 years, 3.1%). Compared with controls without HF, patients more frequently presented cardiovascular or other co-morbidities. The hospital mortality rate was 6.4% and the mortality rate during the 30 days after discharge was 4.4% (3.4% without readmission). Among 30-day survivors, all-cause and HF 30-day readmission rates were 18% (< 70 years, 22%; ≥ 90 years, 13%) and 5%, respectively. Reimbursements among 30-day survivors comprised at least a beta-blocker in 54% of cases, diuretics in 85%, angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) in 67%, a diuretic and ACEI/ARB combination in 23% and a beta-blocker, ACEI/ARB and diuretic combination in 37%. CONCLUSION: Patients admitted for HF presented high rates of co-morbidity, readmission and death at 30 days, and there remains room for improvement in their drug treatments; these findings indicate the need for improvement in return-home and therapeutic education programmes.


Subject(s)
Cardiovascular Agents/therapeutic use , Heart Failure/drug therapy , Hospitalization , Aged , Aged, 80 and over , Case-Control Studies , Comorbidity , Drug Therapy, Combination , Female , France/epidemiology , Heart Failure/diagnosis , Heart Failure/epidemiology , Heart Failure/mortality , Hospital Mortality , Humans , Incidence , Length of Stay , Male , Middle Aged , Patient Discharge , Patient Readmission , Risk Factors , Time Factors , Treatment Outcome
13.
Arch Cardiovasc Dis ; 106(5): 274-86, 2013 May.
Article in English | MEDLINE | ID: mdl-23769402

ABSTRACT

BACKGROUND: The frequencies of treatment for cardiovascular risk factors are poorly documented in large populations, particularly according to the presence or absence of cardiovascular disease (CVD). AIMS: To assess frequencies of reimbursements for antihypertensive, lipid-lowering and antidiabetic medications in France among national health insurance beneficiaries in 2010 and their associations according to age, sex, French regions, level deprivation and the presence of certain CVD. METHODS: Treatment frequencies were calculated among the beneficiaries (58 million people) on the basis of reimbursements for three specific categories of medicinal products in 2010. The presence of CVD was defined by a diagnosis associated with chronic disease status and hospital stays in 2010. RESULTS: Among people aged greater or equal to 20years, treatment frequencies were 22% (men 20% vs. women 23%) for antihypertensives, 15% (14% vs. 16%) for lipid-lowering agents and 6% (6% vs. 5%) for antidiabetic medications. These frequencies were, respectively, 33%, 23% and 8% in patients aged greater or equal to 40years and 55%, 38% and 14% in patients aged greater or equal to 60 years. The frequency of at least one treatment for at least one of the three risk factors was 41% in patients aged greater or equal to 40 years and 66% in patients aged greater or equal to 60 years. Among patients aged greater or equal to 20 years, 22% were treated for at least one risk factor in the absence of CVD and 3% were treated for at least one risk factor in the presence of CVD. Regional differences were observed, with higher frequencies of antihypertensive and antidiabetic use in the North, North-East and Overseas regions. Treatment frequencies increased with level of deprivation, especially for antidiabetics. CONCLUSION: This national study more clearly defines treatment frequencies and the populations and regions with the highest treatment frequencies.


Subject(s)
Antihypertensive Agents/therapeutic use , Cardiovascular Diseases/prevention & control , Diabetes Mellitus/drug therapy , Dyslipidemias/drug therapy , Hypertension/drug therapy , Hypoglycemic Agents/therapeutic use , Hypolipidemic Agents/therapeutic use , Practice Patterns, Physicians'/trends , Adolescent , Adult , Aged , Aged, 80 and over , Antihypertensive Agents/economics , Cardiovascular Diseases/economics , Cardiovascular Diseases/epidemiology , Child , Child, Preschool , Diabetes Mellitus/economics , Diabetes Mellitus/epidemiology , Drug Costs , Drug Utilization/trends , Drug Utilization Review , Dyslipidemias/economics , Dyslipidemias/epidemiology , Female , France/epidemiology , Humans , Hypertension/economics , Hypertension/epidemiology , Hypoglycemic Agents/economics , Hypolipidemic Agents/economics , Infant , Infant, Newborn , Insurance, Health, Reimbursement , Male , Middle Aged , Practice Patterns, Physicians'/economics , Risk Factors , Time Factors , Young Adult
14.
Presse Med ; 41(5): 491-503, 2012 May.
Article in French | MEDLINE | ID: mdl-22401964

ABSTRACT

OBJECTIVES: The objectives of this study were to assess the main characteristics of acute and post-acute care for transient ischemic attack (TIA) and stroke, based on the French national hospitalization databases and their evolutions from 2007 through 2009. METHODS: Hospitalizations with a main diagnosis of stroke were first selected in the 2007, 2008 and 2009 French hospital discharge databases (PMSI-MCO). They were then linked in the corresponding national databases of post-acute hospitalization records (PA), through the common anonymous patient number used in every hospitalization database. RESULTS: In France, 138,601 acute hospitalizations were registered in 2009, 31,674 TIA and 106,927 strokes, of which 91% were in public hospitals. The mean length of stay was 6.4 days for TIA and 12.7 days for stroke. Stroke hospitalization in stroke unit increased from 9.7% in 2007 to 25.9% in 2009 and acute care in hospital having a stroke unit, from 22.9% to 47.4%. A third of stroke patients hospitalized in acute care in 2009 (and not deceased), were linked in the post-acute-care database: 10.4% were in rehabilitations facilities (RF) and 23.4%, in post-acute nursing facilities (PAN), versus respectively 7.5% and 24% in 2007. DISCUSSION: French national hospitalization databases are exhaustive (acute care) or quasi-exhaustive (post-acute care) and can be linked with a good reliability. However, their validity depends on coding accuracy. In this respect, stroke unit hospitalization might be underreported. CONCLUSION: The French national hospital databases showed consistent improvements in stroke care in recent years. At the acute phase, there was an increase in stroke care in both stroke unit and hospital with stroke unit, due to the development of stroke care in France. Furthermore, the proportion of stroke patient discharged in rehabilitation facilities increased from 7.5% to 10.4%.


Subject(s)
Hospitalization/statistics & numerical data , Stroke Rehabilitation , Stroke/therapy , Acute Disease , Adult , Aged , Aged, 80 and over , Female , France/epidemiology , Hospitalization/trends , Humans , Length of Stay/statistics & numerical data , Male , Middle Aged , Patient Transfer/statistics & numerical data , Quality Improvement , Quality of Health Care/statistics & numerical data , Rehabilitation Centers/standards , Rehabilitation Centers/statistics & numerical data , Stroke/diagnosis , Stroke/epidemiology , Time Factors
15.
Eur J Prev Cardiol ; 19(2): 213-20, 2012 Apr.
Article in English | MEDLINE | ID: mdl-21450611

ABSTRACT

OBJECTIVES: The objectives of this study were to describe the hypertensive population and therapeutic management of hypertension in subjects between 18 and 74 years of age in continental France in 2006. METHODS: ENNS was a cross-sectional survey conducted in continental France in 2006-2007. Blood pressure (BP) was measured in a national sample of non-institutionalized adults aged 18-74 years and pharmacological treatment was collected by a self-questionnaire. Hypertension was defined by systolic blood pressure (SBP) ≥140 mmHg, diastolic blood pressure (DBP) ≥90 mmHg, or treatment with BP-lowering drugs. The therapeutic control of treated hypertensive patients was defined by SBP <140 mmHg and DBP <90 mmHg. RESULTS: The prevalence of hypertension was 31.0%. Half of hypertensive subjects reported taking an antihypertensive drug (50.3%) and nearly half of them were treated with a single antihypertensive pharmacological class (44.3%). Overall, among hypertensives, 25.6% had a satisfactory BP control. CONCLUSIONS: Our survey revealed a high prevalence of hypertension in continental France, with only half of the hypertensive subjects receiving pharmacological therapy and one treated out of two with BP at goal. More effective measures are needed to improve clinical management of hypertension.


Subject(s)
Antihypertensive Agents/therapeutic use , Hypertension/drug therapy , Adolescent , Adult , Aged , Antihypertensive Agents/pharmacology , Blood Pressure/drug effects , Blood Pressure Determination , Cross-Sectional Studies , Disease Management , Female , France/epidemiology , Humans , Hypertension/epidemiology , Male , Middle Aged , Multivariate Analysis , Prevalence , Self Report , Young Adult
16.
Circ Cardiovasc Qual Outcomes ; 4(6): 619-25, 2011 Nov 01.
Article in English | MEDLINE | ID: mdl-21972406

ABSTRACT

BACKGROUND: The type of medical coverage in patients with acute myocardial infarction (AMI) may affect their treatment and outcome. METHODS AND RESULTS: We used the reimbursement database from the French National Health Insurance to determine the impact of full medical coverage (Couverture Médicale Universelle Complémentaire, CMUC), a free supplemental insurance for low-income earners <60 years of age, on treatment and outcomes of patients with AMI. The population comprised consecutive patients <60 years of age hospitalized for AMI from January to June 2006 in France. Of 4939 patients with AMI aged <60 years, 587 (12%) were on the CMUC. CMUC patients were younger, with more prior cardiovascular and comorbid conditions. CMUC and non-CMUC patients were admitted to the same types of institutions, including academic hospitals and private clinics. The use of cardiac catheterization and coronary interventions was similar (adjusted relative risk, 0.97; 95% confidence interval, 0.91-1.05; P=0.45). In-hospital mortality was also comparable (3.1% versus 2.8%, P=0.69). There was no difference in early use of secondary prevention medications after multivariate adjustment. At 30 months, survival and acute coronary syndrome-free survival were lower in CMUC patients (trend, not significant after adjustment). Long-term adherence to statin therapy was lower in CMUC patients (64% versus 77%; adjusted relative risk, 0.82; 95% confidence interval, 0.73-0.92). CONCLUSIONS: Free full coverage for socially deprived people levels inequalities in the acute and midterm treatment of AMI patients. However, full reimbursement per se is not sufficient to ensure optimal patient adherence to secondary prevention medications and may not be enough to prevent an excess of long-term events.


Subject(s)
Myocardial Infarction/economics , Myocardial Infarction/epidemiology , Poverty , Quality of Health Care , Registries , Adult , Angioplasty , Cardiac Catheterization , Coronary Vessels/surgery , Disease-Free Survival , Female , France , Humans , Insurance, Health, Reimbursement , Male , Middle Aged , Myocardial Infarction/mortality , Myocardial Infarction/therapy , National Health Programs , Quality of Health Care/statistics & numerical data , Survival Analysis , Universal Health Insurance
17.
Arch Cardiovasc Dis ; 104(5): 332-42, 2011 May.
Article in English | MEDLINE | ID: mdl-21693370

ABSTRACT

BACKGROUND: An ageing population and the extension of indications will in all probability result in an increasing number of cardiac device implantations. METHODS: Patients implanted in 2008 and 2009 were identified by means of the French National Hospital Discharge database to establish the implantation rate and the National Health Insurance (NHI) Information System database for patient profiles (76% of the population). RESULTS: Of the 64,306 pacemaker implantations (1003.7 per million inhabitants [pmi]) in 2009, 21.4% were single chamber, 75.4% double chamber and 3.2% triple chamber (CRT-P). Of the 9028 cardioverter-defibrillator implantations (140.8 pmi) in 2009, 30.1% were single chamber, 27.5% double chamber and 42.5% triple chamber (CRT-D), accounting for 65% of cardiac resynchronization therapy (CRT) implants. Among NHI beneficiaries, 58.6% of cardioverter-defibrillators were implanted for primary prevention. Between 2008 and 2009, CRT-P implantations increased by 8.8% and CRT-D implantations by 29.3%. Regional variations in implantation rates were observed regarding single-chamber pacemakers (15-33%) and CRT-D among CRT (46.2-73.8%). Pacemaker implantations cost €158.4 million overall, 4.5% of which was for CRT-P; cardioverter-defibrillator implantations cost €96 million, 49% of which was for CRT-D. For NHI beneficiaries, 11.9% of CRT-P patients and 6.5% of CRT-D patients already had a device of the same type implanted in the 3 preceding years. CONCLUSION: The results confirm the increase in cardioverter-defibrillator implantations in France. The implantation rate remains lower than that in the USA but falls within the European average. Reasons behind significant regional variations in implantation rates need further study.


Subject(s)
Cardiac Pacing, Artificial/statistics & numerical data , Defibrillators, Implantable/statistics & numerical data , Electric Countershock/statistics & numerical data , Heart Diseases/therapy , Pacemaker, Artificial/statistics & numerical data , Practice Patterns, Physicians'/statistics & numerical data , Preventive Health Services/statistics & numerical data , Aged , Aged, 80 and over , Cardiac Pacing, Artificial/economics , Cardiovascular Agents/therapeutic use , Chi-Square Distribution , Cost-Benefit Analysis , Databases as Topic , Defibrillators, Implantable/economics , Electric Countershock/economics , Electric Countershock/instrumentation , Equipment Design , Female , France/epidemiology , Health Care Costs , Healthcare Disparities , Heart Diseases/epidemiology , Humans , Male , Middle Aged , National Health Programs/statistics & numerical data , Pacemaker, Artificial/economics , Practice Patterns, Physicians'/economics , Preventive Health Services/economics , Prosthesis Design , Residence Characteristics , Time Factors
18.
Cerebrovasc Dis ; 30(4): 346-54, 2010.
Article in English | MEDLINE | ID: mdl-20693789

ABSTRACT

BACKGROUND: Nationwide evaluations of the burden of stroke are scarce. We aimed to evaluate trends in stroke and transient ischemic attack (TIA) hospitalization, in-hospital case fatality rates (CFRs) and mortality rates in France during 2000-2006. METHODS: Hospitalizations for stroke and TIA were determined from National Hospital Discharge Diagnosis Records that used the International Classification of Disease, 10th revision, codes I60, I61, I63, I64, G45, G46. CFRs and mortality rates were estimated from the national death certificates database. RESULTS: The total number of stays for stroke increased between 2000 and 2006 (88,371 vs. 92,118) contrasting with a decrease in that for TIA. The age-standardized (European population) hospitalization rates for TIA decreased in men (52.2 vs. 44.5/100,000/year, p = 0.002), whereas they remained stable in women (32.4 vs. 31.0/ 100,000/year). Concerning stroke, a decrease in hospitalization rates was observed in both men (from 135.3 to 123.4/ 100,000/year, p < 0.001) and women (from 85.1 to 80.7, p < 0.001). Whatever the age group and the sex, a sharp decrease in in-hospital stroke CFRs was noted. In addition, a 23% decrease in mortality rates was observed. This decrease was greater in patients >65 years. CONCLUSION: Our results demonstrate a decline in hospitalization rates for stroke, and in both stroke CFRs and mortality rates between 2000 and 2006. Improvements in stroke prevention and acute stroke care may have contributed to these results, and may have been initiated by recent advances in health policy with regard to this disease in France.


Subject(s)
Health Surveys , Hospitalization/trends , Ischemic Attack, Transient/epidemiology , Stroke/epidemiology , Aged , Aged, 80 and over , Female , France , Humans , Ischemic Attack, Transient/drug therapy , Ischemic Attack, Transient/mortality , Length of Stay/trends , Longitudinal Studies , Male , Retrospective Studies , Stroke/drug therapy , Stroke/mortality , Survival Rate , Tissue Plasminogen Activator/therapeutic use
19.
Arch Cardiovasc Dis ; 103(6-7): 363-75, 2010.
Article in English | MEDLINE | ID: mdl-20800800

ABSTRACT

BACKGROUND: International guidelines recommend long-term use of evidence-based treatment (EBT) combining beta-blockers, aspirin/clopidogrel, statins and either angiotensin-converting enzyme inhibitors or angiotensin receptor blockers (ACEIs/ARBs) after a myocardial infarction (MI), to reduce cardiac morbidity and mortality. AIMS: To evaluate medication adherence after hospital admission for MI and the relationship with mortality and readmission for acute coronary syndrome. METHODS: Observational, 30-month follow-up of patients admitted for acute MI in France in the first half of 2006 and still alive 6 months later. Data from the national hospital discharge database and the outpatient medications reimbursement database were linked for all patients covered by the general health insurance scheme (70% of the French population). A patient was considered as adherent when the proportion of days covered by a filled prescription was greater than 80%. RESULTS: The proportion of nonadherent patients was 32.0% for beta-blockers, 24.0% for statins, 22.7% for ACEIs/ARBs, 18.3% for aspirin/clopidogrel and 50.0% for combined EBT. Adherence to EBT was decreased significantly by age greater than 74 years, comorbidities and full healthcare coverage for low earners. Prior EBT use and stent implantation, before or during index hospitalization, increased adherence. After adjustment for patient characteristics and management, prior use of each class decreased mortality. Nonadherence to EBT after MI increased mortality and readmission (hazard ratio=1.43, P<0.0001). CONCLUSION: After MI, nonadherence to EBT is associated with a marked increase in all-cause mortality and readmission for acute coronary syndrome. Cost-effective strategies for adherence improvement should be developed among patient groups with poor adherence.


Subject(s)
Acute Coronary Syndrome/drug therapy , Cardiovascular Agents/therapeutic use , Evidence-Based Medicine , Medication Adherence , Myocardial Infarction/drug therapy , Patient Readmission , Acute Coronary Syndrome/mortality , Adrenergic beta-Antagonists/therapeutic use , Adult , Aged , Aged, 80 and over , Angiotensin II Type 1 Receptor Blockers/therapeutic use , Angiotensin-Converting Enzyme Inhibitors/therapeutic use , Databases as Topic , Disease-Free Survival , Drug Prescriptions , Drug Therapy, Combination , Female , France/epidemiology , Humans , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Insurance, Pharmaceutical Services , Kaplan-Meier Estimate , Male , Medication Adherence/statistics & numerical data , Middle Aged , Myocardial Infarction/mortality , Odds Ratio , Patient Readmission/statistics & numerical data , Platelet Aggregation Inhibitors/therapeutic use , Proportional Hazards Models , Risk Assessment , Risk Factors , Time Factors , Treatment Outcome
20.
Arch Cardiovasc Dis ; 102(4): 279-92, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19427605

ABSTRACT

BACKGROUND: Both French and international guidelines recommend long-term use of betablockers, antiplatelet drugs, statins, angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers (ACE-I/ARB) after a myocardial infarction (MI), but data on their combined use are scarce in France. AIMS: To evaluate the use of combined medication 6 months after hospital admission for MI and the factors that can significantly influence their use. METHODS: All hospital admissions for MI in France from January to June 2006 were selected from the national hospital discharge database. Data on medications used 6 months before and after hospitalization for patients covered by the general health insurance scheme (70% of French population) were collected from the reimbursement information system. A medication was considered to be used when there were more than three reimbursement applications over the 6 months following the index episode. Comorbidities were ascertained from the use of disease-specific medication reimbursements and registration in the national database of full coverage for 30 long-term disorders. RESULTS: Of the 11,671 patients included, 82% were reimbursed for betablockers, 92% for antiplatelets, 85% for statins, 80% for ACE-I/ARBs and 62% for all four classes. After adjustment, significant underuse was found for women, the elderly and those with several comorbidities. Treatment at a university hospital or high-volume centre, follow-up by a cardiologist and use of revascularization procedures were associated with improved rates of combination therapy use. CONCLUSION: Overall, use of recommended medications after MI in France is satisfactory, though not optimal. Specific recommendations focusing on subgroups such as older patients or those with comorbidities, as well as information directed towards non-specialized healthcare professionals, should help to improve appropriate use of these medications.


Subject(s)
Cardiovascular Agents/therapeutic use , Hospitalization/statistics & numerical data , Myocardial Infarction/drug therapy , Myocardial Infarction/prevention & control , Practice Patterns, Physicians'/statistics & numerical data , Secondary Prevention , Adult , Aged , Aged, 80 and over , Comorbidity , Databases as Topic , Drug Prescriptions/statistics & numerical data , Drug Therapy, Combination , Female , France/epidemiology , Guideline Adherence , Health Care Surveys , Humans , Insurance, Health, Reimbursement/statistics & numerical data , Insurance, Pharmaceutical Services/statistics & numerical data , Male , Middle Aged , Myocardial Infarction/epidemiology , National Health Programs/statistics & numerical data , Practice Guidelines as Topic , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...